ENTOCORT enema (Budesonide ENEMA) 2.3mg/115ml

ENTOCORT enema contains budesonide 2.3mg/115ml for localized treatment of inflammatory bowel conditions. This corticosteroid enema delivers targeted relief directly to the affected area. Suitable for adults and children over 12. Keep at room temperature and protect from light.

Strength

2.3mg/115ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

TILLOTTS PHARMA AG

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ENTOCORT enema is used to treat mild to moderate ulcerative colitis and other inflammatory bowel conditions. It helps reduce inflammation in the lower colon and rectum. This localized treatment is often prescribed when oral medications are not sufficient. It may also be used for maintenance therapy to prevent flare-ups.

Side Effects

ENTOCORT enema works by reducing swelling and irritation in the intestines. Users may notice reduced urgency and discomfort during bowel movements. Some people experience temporary relief within a few days of starting treatment. Effects vary by individual and condition severity.

Precautions & Warnings

Store ENTOCORT enema at room temperature away from moisture and heat. Shake the bottle gently before use to ensure even distribution. Avoid exposure to extreme temperatures. Keep out of reach of children. Discard any unused medication after the expiration date.

Avoid Interactions

ENTOCORT enema has minimal systemic absorption, but interactions with strong CYP3A4 inhibitors like ketoconazole may increase budesonide levels. Avoid grapefruit juice as it can affect metabolism. Consult a healthcare provider before combining with other steroids or immunosuppressants.

Frequently Asked Questions

Lie on your left side and insert the nozzle into the rectum. Slowly squeeze the bottle to empty its contents, then remain in position for at least 30 minutes.

Possible side effects include headache, nausea, or mild rectal irritation. Most effects are temporary and resolve with continued use.

Consult a healthcare provider before using any medication during pregnancy. Budesonide is classified as a pregnancy category B drug.

Some users notice improvement within a few days, but full effects may take up to two weeks of consistent use.

ENTOCORT enema is approved for children over 12 years old. Dosage and duration should be determined by a pediatrician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.